<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Repurposed drug therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/repurposed-drug-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 11:58:58 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Repurposed drug therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Study by Mass General Brigham Reveals Gabapentin Linked to Extended Survival in Glioblastoma Patients</title>
		<link>https://bioengineer.org/study-by-mass-general-brigham-reveals-gabapentin-linked-to-extended-survival-in-glioblastoma-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 May 2025 16:50:12 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer neuroscience]]></category>
		<category><![CDATA[Cancer neuroscience advancements]]></category>
		<category><![CDATA[Gabapentin glioblastoma survival]]></category>
		<category><![CDATA[Gabapentin survival benefit]]></category>
		<category><![CDATA[Glioblastoma treatment]]></category>
		<category><![CDATA[Mass General Brigham research]]></category>
		<category><![CDATA[Neuro-oncology treatment repurposing]]></category>
		<category><![CDATA[Repurposed drug therapy]]></category>
		<category><![CDATA[Thrombospondin-1 biomarker]]></category>
		<category><![CDATA[Thrombospondin-1 biomarker role]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-by-mass-general-brigham-reveals-gabapentin-linked-to-extended-survival-in-glioblastoma-patients/</guid>

					<description><![CDATA[A groundbreaking retrospective study conducted by researchers at Mass General Brigham has unveiled a promising correlation between the use of gabapentin—a widely prescribed anticonvulsant and neuropathic pain medication—and extended survival in patients suffering from glioblastoma (GBM), the deadliest and most common primary brain tumor in adults. Published recently in Nature Communications, this study reveals that [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">245325</post-id>	</item>
	</channel>
</rss>
